Clinical research studies currently under way at Providence Heart and Vascular Institute include:
- Drug-coated/eluting stents
- Providence Heart and Vascular Institute has been instrumental in the research and evaluation of drug-coated/eluting stent therapy and continues with studies of this developing technology. Drug-coated stents have been shown to reduce the incidence of restenosis or reclosure of heart vessels requiring stenting.
- PFO closure devices to prevent recurrent strokes
- Heart failure therapies
- New heart valve technology and procedures
- Gene therapy for people with heart disease
- Atrial fibrillation treatments
- New anti-platelet therapies
- Diabetes research in the cardiovascular setting
- Peripheral vascular disease treatments